Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin

Diagn Microbiol Infect Dis. 2023 Jul;106(3):115947. doi: 10.1016/j.diagmicrobio.2023.115947. Epub 2023 Mar 29.

Abstract

We measured antibiotic penetration and bioavailability in staphylococcus biofilms using simulated humanized concentrations of fluorescent vancomycin plus or minus rifampin. Vancomycin percent recovery across biofilm layers was:upper = 46%, middle = 40%, and lower = 33%. Vancomycin plus rifampin was not significantly different (P = 0.65). Addition of rifampin did not improve vancomycin penetration across biofilm layers.

Keywords: Biofilm; Microscopy; Rifampin; Staphylococcus epidermidis; Vancomycin.

MeSH terms

  • Anti-Bacterial Agents
  • Biofilms
  • Biological Availability
  • Humans
  • Microbial Sensitivity Tests
  • Rifampin / pharmacology
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus
  • Staphylococcus epidermidis
  • Vancomycin*

Substances

  • Vancomycin
  • Rifampin
  • Anti-Bacterial Agents